We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-1.27%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$283B
AUM Growth
+$27.4B
Cap. Flow
+$30.5B
Cap. Flow %
10.78%
Top 10 Hldgs %
36.77%
Holding
11,338
New
1,654
Increased
4,102
Reduced
3,903
Closed
1,507

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.35%
2 Technology 1.76%
3 Financials 1%
4 Communication Services 0.83%
5 Healthcare 0.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KUST
9301
CALL
Kustom Entertainment Inc
KUST
$759K
0
KPRX icon
9302
Kiora Pharmaceuticals
KPRX
$11.7M
$78K ﹤0.01%
+97
New +$82.4K
VATE icon
9303
INNOVATE Corp
VATE
$165M
$78K ﹤0.01%
1,907
+175
+10% +$6.54K
NOACW
9304
DELISTED
Natural Order Acquisition Corp. Warrant
NOACW
$78K ﹤0.01%
153,412
+805
+0.5% +$492
GLRE icon
9305
Greenlight Captial
GLRE
$506M
$77K ﹤0.01%
10,381
-10,175
-49% -$84.9K
BCEL
9306
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$77K ﹤0.01%
12,271
-346
-3% -$2.31K
SGTX
9307
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$77K ﹤0.01%
+1,049
New +$80.7K
IIAC.WS
9308
DELISTED
Investindustrial Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class
IIAC.WS
$77K ﹤0.01%
59,597
-1,274
-2% -$1.59K
VANI icon
9309
CALL
Vivani Medical
VANI
$122M
$76K ﹤0.01%
7,967
-19,266
-71% -$217K
TCRT icon
9310
CALL
Alaunos Therapeutics
TCRT
$4.86M
$75K ﹤0.01%
276
+99
+56% +$30.3K
TBCPW
9311
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$75K ﹤0.01%
100,010
SSAAW
9312
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$75K ﹤0.01%
100,000
-935
-0.9% -$743
HIGA.WS
9313
DELISTED
H.I.G. Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HIGA.WS
$75K ﹤0.01%
109,297
+45
+0% +$42
XNET
9314
CALL
Xunlei
XNET
$326M
$74K ﹤0.01%
25,800
-9,700
-27% -$34.5K
EQOS
9315
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$74K ﹤0.01%
+22,635
New +$115K
IVAN.WS
9316
DELISTED
Ivanhoe Capital Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
IVAN.WS
$74K ﹤0.01%
50,917
+300
+0.6% +$435
YAC.WS
9317
DELISTED
Yucaipa Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A
YAC.WS
$74K ﹤0.01%
70,281
+700
+1% +$833
DYAI icon
9318
CALL
Dyadic International
DYAI
$36.4M
$73K ﹤0.01%
+13,200
New +$61.5K
LXRX icon
9319
CALL
Lexicon Pharmaceuticals
LXRX
$1.1B
$73K ﹤0.01%
+15,100
New +$62K
SUNW
9320
PUT
DELISTED
Sunworks, Inc.
SUNW
$73K ﹤0.01%
11,900
-15,700
-57% -$123K
TZPSW
9321
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$73K ﹤0.01%
116,600
APRE icon
9322
Aprea Therapeutics
APRE
$8.05M
$72K ﹤0.01%
+708
New +$64.3K
HIX
9323
Western Asset High Income Fund II
HIX
$355M
$72K ﹤0.01%
+10,118
New +$75.1K
DOMA.WS
9324
DELISTED
Doma Holdings, Inc. Warrants, Every 25 warrants will be exercisable for one share of Common Stock at an exercise price of $287.50 per share of Common Stock
DOMA.WS
$72K ﹤0.01%
+50,985
New +$63.3K
AQB icon
9325
AquaBounty Technologies
AQB
$6.02M
$71K ﹤0.01%
+872
New +$81.7K

Similar funds

Jane Street's Q3 2021 Portfolio in Review

As of Q3 2021, Jane Street held 11,338 positions worth $283B, up 11% from $256B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $30.5B of net new capital in Q3 2021, opening 1,654 new positions and adding to 4,102 existing holdings. Its largest new stake was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.3% of assets, down from 2.5% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $1.01B trimmed.

  • Jane Street's largest Q3 2021 buy was Vanguard FTSE Europe ETF: 5,046,582 shares worth $331M.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $1.64B increase.
  • Jane Street's biggest Q3 2021 reduction was iShares MBS ETF, cutting an estimated $1.01B.
  • Jane Street fully exited Vanguard Tax-Exempt Bond Index Fund in Q3 2021, selling an estimated $338M.
  • Jane Street's ten largest holdings make up 37% of its $283B portfolio in Q3 2021.
  • Jane Street opened 1,654 new positions and closed 1,507 in Q3 2021.
  • Jane Street's portfolio value rose 11% quarter-over-quarter to $283B.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.